Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for September 2008
September 2, 2008
- Shionogi & Co., Ltd. to Acquire Sciele Pharma, Inc.
- Novartis Decides Not to Pursue Further Development of Aurograb
- Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ranbaxy Generic Product before November 2011
- ZymoGenetics Earns Milestone Payment for RECOTHROM European Filing
- Value of Direct-to-Consumer Drug Advertising Oversold, Study Finds
- America's Pharmaceutical Research Companies Respond to Hurricane Gustav's Landfall
- Takeda and Affymax Provide Clinical Development Update for Hematide in Chemotherapy-Induced Anemia
- HIV/AIDS Update - Updated Labeling for Norvir (ritonavir) Soft Capsule and Oral Solution
- IVAX Diagnostics Reports Sale of Parent Company's Interest
September 3, 2008
- Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
- Consumer Reports Urges Chronic Headache Sufferers to Examine Their Use of Pain Relief Drugs
- GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza
- Léger Survey Reports 84 Per Cent of Ontario Physicians Feel Patients May Be Addicted to Prescription Painkillers
- Study: Teen Suicide Spike Was No Fluke
- Merck and ZymoGenetics Restructure Partnership
- Zentiva N.V. – Sanofi Offer Update
September 4, 2008
- Wolters Kluwer Health Reaches Agreement to Acquire UpToDate
- Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies
- FDA: Manufacturers of TNF-Blocker Drugs Must Highlight Risk of Fungal Infections
September 5, 2008
- Phase Forward Acquires Clarix LLC, Innovation Leader in Web-Integrated Interactive Response Technology (IRT) for Clinical Trials
- Free Drug Samples May End Up Costing Uninsured More
- Inauguration of the Sanofi-Aventis Central Anti-Counterfeit Laboratory in Tours
- Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
- Reps. Dingell, Stupak Write Schering-Plough and Merck on Vytorin-Cancer Link
- Prescription Drug Advertising Subject of New FDA Web Site for Consumers
- FDA to Post Quarterly Report of Potential Safety Issues
September 8, 2008
- New Low-Dose Oral Contraceptive Yaz Launched in Europe
- FDA Issues Warning Letter for Forest Laboratories' Bystolic Tablets
- GlaxoSmithKline plc - Directorate Change
September 9, 2008
- Pharmas Challenged by Product Risk and Philanthropy Fatigue
- Pharmas Challenged by Product Risk and Philanthropy Fatigue
- SDI Reports: Prescribers May Influence Patient Adherence by Authorizing More Refills
- Federal Court of Appeals in a Divided Decision Reverses District Court Ruling Dismissing Vioxx Securities Class Action
- Solvay Pharmaceuticals Acquires Innogenetics
September 10, 2008
- Prologue Acquisition Update and Termination of Linkcon Business Combination
- Sanofi-Aventis: Upcoming Change of Chief Executive Officer
- ImClone Systems Issues Statement
September 11, 2008
- Cell Genesys Reconfirms Plans with FDA for Phase 3 Program for GVAX Immunotherapy While on Partial Clinical Hold
- King to Commence Cash Tender Offer for Alpharma at $37 Per Share
- Bristol-Myers Squibb Submits Letter to ImClone Board of Directors
- Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
- FDA MedWatch- Rituxan (rituximab)- Important New Safety Information Regarding Progressive Multifocal Leukoencephalopathy With The Use Of Rituxan
- Alpharma Urges Shareholders to Take No Action with Respect to King Pharmaceuticals' Announced Intent to Commence a Tender Offer
September 12, 2008
- ARIAD Announces Merger with ARIAD Gene Therapeutics, Inc.
- ImClone Systems Submits Letter to Bristol-Myers Squibb
- King Commences Cash Tender Offer for Alpharma at $37 Per Share
- NACDS 2008 Chain Pharmacy Industry Profile Showcases Extraordinary Impact of Pharmacies as a Frontline Healthcare Provider, Significantly Impacting Economy
September 15, 2008
- WebMD to Acquire QualityHealth.com
- Betaseron to Offer the Thinnest Needle in Multiple Sclerosis
- Online Video is an Emerging Channel for Physicians to Connect with Pharmaceutical Companies
- Newer Antipsychotics No Better Than Older Drug in Treating Child and Adolescent Schizophrenia
- SeraCare Life Sciences Announces Completion of SEC Investigation
- Teva Announces Appellate Court Reverses Generic Risperdal Exclusivity Decision
- Pfizer Launches New Medicine Safety Website to Help Healthcare Professionals and Patients Make Better Informed Decisions about Treatment Options
- Cybercitizen Health Europe Study Reveals How European Consumers Use the Internet for Health Information
September 16, 2008
- Charles River Acquires MIR Preclinical Services
- Bayer HealthCare Acquires German DIREVO Biotech AG
- GSK and XenoPort Announce Submission of NDA Requesting FDA Approval of Solzira for Restless Legs Syndrome
- MannKind and Pfizer Announce Collaboration for Certain Exubera Patients to Transition to MannKind's Inhaled Insulin Therapy
- Cytokinetics Announces Strategic Realignment of Workforce and Operations
September 17, 2008
- FDA Issues Warning Letters to Ranbaxy Laboratories Ltd., and an Import Alert for Drugs from Two Ranbaxy Plants in India
- Biovail Acquires Prestwick Pharmaceuticals
- ViRexx Announces Failure to Secure an Alternative Equivalent Funder to Replace LM Funds Corp.
- Information on the Removal From Office of Mr. Gerard Le Fur and the Appointment of Mr. Chris Viehbacher as Chief Executive Officer
- Ranbaxy, Statement on FDA Letters
- André Hoffmann Acquires Expanded Position in MedAssurant and Joins Board of Directors
September 18, 2008
- Neose Technologies to Sell its Assets to Novo Nordisk and BioGeneriX
- Ranbaxy Laboratories, Ltd., Retains Former New York City Mayor Rudy Giuliani to Lead Team in Resolution of Issues Raised by U. S. Food & Drug Administration
- SCT Receives Letter From Health Canada and Verbal Request From FDA to Place a Clinical Hold on Its REGENESIS Phase IIb Stroke Trial
September 19, 2008
- Erbitux Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
- Maxygen and Astellas Announce Global Agreement to Develop New Therapies for Autoimmune Diseases and Transplantation
- FDA Drug Safety Newsletter: Postmarketing Reviews
September 22, 2008
- Encorium Announces the Initiation of a Strategic Partnership With Prologue Research
- Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
- Angiotech Announces Reorganization and Cost Reduction Initiatives, Updates Financial Outlook
- Med Ad News Names Novartis Pharmaceutical Company of the Year
- AstraZeneca Receives Six Months Pediatric Exclusivity for Casodex (bicalutamide) from the FDA
- Proposed Class Action Settlement and Class Certification Regarding Wholesale Drug Pricing May Affect Consumers and Third-Party Payors
September 23, 2008
- Bristol-Myers Squibb to Commence Cash Tender Offer for ImClone Systems at $62.00 per share
- Half of Trials Supporting FDA Applications Go Unpublished
- FDA MedWatch - Tarceva (erlotinib) - Cases of Hepatic Failure and Hepatorenal Syndrome, Including Fatalities, Have Been Reported During Use of Tarceva
- Icahn Responds to Cornelius
September 24, 2008
- FDA Warns Companies to Stop Marketing Unapproved Ophthalmic Balanced Salt Solution Drug Products and Topical Drug Products Containing Papain
- Roche Completes Acquisition of ARIUS
- Lilly Set to Become First Pharmaceutical Research Company to Disclose Physician Payments
- Elias A. Zerhouni to End Tenure as Director of the National Institutes of Health
September 25, 2008
- Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
- TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds
- Medicis Announces Intent to Restate Financial Statements
- NICE Guidelines are Set to Improve Care and Management of Children, Young People and Adults With ADHD
- Canon Communications’ R&D Directions Magazine Wins Bronze Eddie Award
- AARP Rx Watchdog Report Finds Specialty Drug Prices Soar
September 26, 2008
- Alpharma Board of Directors Unanimously Rejects King Pharmaceuticals' Unsolicited Tender Offer as "Financially Inadequate"
- CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
- Online European Consumers Turn to Search Engines and Wikipedia for Health Information
- Crucell's Swiss Affiliate Berna Biotech to Cease All Animal Testing
- FDA MedWatch - Epoetin alfa- Preliminary Safety Findings Show More Deaths In Patients Given Epoetin-alpha Versus Placebo
September 29, 2008
- Cardinal Health Plans to Spin Off Clinical and Medical Products Businesses, Creating Global Leader in Medical Technology
- WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
- FDA Issues Several Letters for ADHD Drugs
- FDA Continues to Review Prasugrel New Drug Application
- FDA Grants Lilly's Alimta (Pemetrexed for Injection) Third U.S. Approval
- ImClone Systems Issues Statement
- Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company's Sales and Promotional Practices
